previous compound ID: 2383 next compound
InChIKey: VSJKWCGYPAHWDS-FQEVSTJZSA-N
SMILES: CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=CC5=CC=CC=C5N=C4C3=C2)O

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"GW Carlile" "J Goepp" "JW Hanrahan" "DY Thomas" "J Liao" "D Rotin" "R Robert" "B Kus" "E Matthes" "SD Macknight"

chemical graph of compound 2383





CID is 24360
synonyms found at PubChem are:
camptothecin, Camptothecine, (S)-(+)-Camptothecin, 7689-03-4, Campathecin, (+)-Camptothecine, d-Camptothecin, 20(S)-Camptothecine, (+)-Camptothecin, 21,22-Secocamptothecin-21-oic acid lactone, NSC94600, (S)-Camptothecin, 20(S)-Camptothecin, Camptothecine (8CI), Camptothecine (S,+), CHEMBL65, UNII-XT3Z54Z28A, MLS000766223, XT3Z54Z28A, CHEBI:27656, VSJKWCGYPAHWDS-FQEVSTJZSA-N, Camptothecin, Camptotheca acuminata, NSC-94600, (4S)-4-ethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, Camptothecin derivative, Q-200785, (S)-4-ethyl-4-hydroxy-1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, (S)-4-Ethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14-(4H,12H)-dione, 1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-, (S)-, 4-Ethyl-4-hydroxy-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)dione, SR-01000075798, SR-01000597379, d-camptothecine, (s)-camptothecine, Camptothecin,(S), ( )-Camptothecin, (S)-4-ethyl-4-hydroxy-1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-, (4S)-, 1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-, (4S)-, 1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-, (S)-, 4-ETHYL-4-HYDROXY-1,12-DIHYDRO-4H-2-OXA-6,12A-DIAZA-DIBENZO[B,H]FLUORENE-3,13-DIONE, Prestwick_102, CAMPTOTHECINUM, (+)-Camptothecin;, PubChem10183, Spectrum_000299, Tocris-1100, SpecPlus_000712, AC1L2NDR, Prestwick0_000200, Prestwick1_000200, Prestwick2_000200, Prestwick3_000200, Spectrum2_000903, Spectrum3_001203, Spectrum4_000738, Spectrum5_001126, Lopac-C-9911, D09YDM, AC1Q2C5X, SCHEMBL6038, Lopac0_000341, BSPBio_000159, BSPBio_002586, KBioGR_001036, KBioSS_000779, KBioSS_002283, cid_24360, DivK1c_000826, DivK1c_006808, SPECTRUM1502232, SPBio_000746, SPBio_002080, AC1Q2C60, BPBio1_000175, Jsp000050, DTXSID0030956, HMS502J08, KBio1_000826, KBio1_001752, KBio2_000779, KBio2_003347, KBio2_005915, KBio3_002086, BIC8442, 4-Ethyl-4-hydroxy-1H-pyrano-[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, MolPort-001-738-745, NINDS_000826, ZX-AFC000426, Bio1_000400, Bio1_000889, Bio1_001378, HMS1568H21, HMS1921N08, HMS2089F08, HMS2095H21, HMS3261E03, HMS3654D13, HMS3712H21, ZINC105309, (S)-4-Ethyl-4-hydroxy-1H-pyrano-[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, ACT02668, BCP02857, ZX-AT019935, Tox21_500341, AC-202, BBL033963, BDBM50008923, BG0120, CCG-40255, GR-301, s1288, STK801886, AKOS004119861, API0001826, CS-1049, DB04690, KS-5235, LP00341, MCULE-1654983682, SDCCGMLS-0066688.P001, CAS-2114454, IDI1_000826, NCGC00015290-01, NCGC00016994-01, NCGC00016994-02, NCGC00016994-03, NCGC00016994-04, NCGC00016994-05, NCGC00016994-06, NCGC00016994-07, NCGC00016994-08, NCGC00016994-09, NCGC00016994-10, NCGC00016994-11, NCGC00016994-12, NCGC00016994-16, NCGC00024997-01, NCGC00024997-02, NCGC00024997-03, NCGC00024997-04, NCGC00024997-05, NCGC00024997-06, NCGC00178592-01, NCGC00178592-02, NCGC00261026-01, AJ-11194, AK-39842, AN-16065, BC203226, BR-39842, HY-16560, K332, KB-38584, NCI60_042105, OR014824, SMR000445686, SY010324, AX8038860, ST2412720, EU-0100341, FT-0623436, N1868, C 9911, C01897, J10012, M01564, S-2515, 32320-EP2270008A1, 32320-EP2272827A1, 32320-EP2275420A1, 32320-EP2277507A1, 32320-EP2277865A1, 32320-EP2280013A1, 32320-EP2281815A1, 32320-EP2286795A1, 32320-EP2286812A1, 32320-EP2289892A1, 32320-EP2292615A1, 32320-EP2292617A1, 32320-EP2295055A2, 32320-EP2295416A2, 32320-EP2298748A2, 32320-EP2298764A1, 32320-EP2298765A1, 32320-EP2298778A1, 32320-EP2301933A1, 32320-EP2305640A2, 32320-EP2305642A2, 32320-EP2305671A1, 32320-EP2308855A1, 32320-EP2311453A1, 32320-EP2311827A1, 32320-EP2311840A1, AB00052452-08, AB00052452-09, AB00052452_10, (S)-(+)-Camptothecin, >=90% (HPLC), powder, 157594-EP2277507A1, 157594-EP2286795A1, 179002-EP2280013A1, 689C034, SR-01000075798-1, SR-01000075798-4, SR-01000597379-1, SR-01000597379-3, BRD-K37890730-001-09-4, BRD-K37890730-001-10-2, (S)-4-ethyl-4-hydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]florene-3,13-dione, (S)-4-ethyl-4-hydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione, 4-Ethyl-4-hydroxy-1H-pyrano-[3[,4[:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, Topotecan Related Compound C, United States Pharmacopeia (USP) Reference Standard, (19S)-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.0(2),(1)(1).0?,?.0(1)?,(2)?]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione, 1H-Pyrano[3',7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-, (S)-, 4(S)-Ethyl-4-hydroxy-1H-pyrano-[3',4':6,7]indolizino[1,2-b]quinoline-3,14 (4H,12H)-dione, 4-ethyl-4-hydroxy-(4S)-3,4,12,14-tetrahydro-1H-pyrano[3'',4'':6,7]indolizino[1,2-b]quinoline-3,14-dione, 4-Ethyl-4-hydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione (camptothecin or CPT), 4-Ethyl-4-hydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione (Camptothecin), 4-Ethyl-4-hydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione (CPT, Camptothecin)